![](https://investorshub.advfn.com/uicon/81806.png?cb=1635633872)
Thursday, February 11, 2010 2:32:30 PM
SenoRx CEO Malchow takes indefinite medical leave of absence to deal with cancer treatment
Companies:Senorx, Inc.
On Monday February 8, 2010, 10:02 am EST
IRVINE, Calif. (AP) -- Medical device maker SenoRx Inc. said Monday that CEO Lloyd H. Malchow is taking an indefinite medical leave of absence while he receives treatment for an unspecified cancer.
President and Chief Operating Officer John T. Buhler will serve as acting CEO while Malchow is on leave. Buhler, who joined the company in May 2008, has been president and COO since October 2009.
SenoRx said Malchow will still serve as a board member and be involved in major strategic decisions during his medical leave.
The company's stock was flat at $7.32 in morning trading.
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM